MedPath

NRA-APIXABAN

NRA-APIXABAN

Approved
DIN Number

02526050

Drug Class

Human

Market Date

Oct 5, 2022

Company
HC

nora pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02526050
AIG Number0153051001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AF02 APIXABAN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification20:12.04.14
Health Canada Classification

ACTIVE INGREDIENTS (1)

APIXABANActive
Strength: 2.5 MG
Monograph: APIXABAN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.